REQUEST A DEMO
Total
USD $0.00
Search more companies

Salus Veletrgovina D.o.o. (Slovenia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Salus Veletrgovina D.o.o. Profile Updated: November 24, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

SALUS, Ljubljana, d. d offers services including pricing, medical support, promotion, sales, regulatory services, pharmacovigilance, distribution, and storage. The company serves as a partner for commercialization and distribution to pharmaceutical and biotech companies in 17 countries in Central and Eastern Europe.

Headquarters
46a Litostrojska Road
Ljubljana; Osrednjeslovenska; Postal Code: 1000

Contact Details: Purchase the Salus Veletrgovina D.o.o. report to view the information.

Website: http://www.salus.si

Basic Information
Total Employees:
Purchase the Salus Veletrgovina D.o.o. report to view the information.
Outstanding Shares:
Purchase the Salus Veletrgovina D.o.o. report to view the information.
Registered Capital:
Purchase the Salus Veletrgovina D.o.o. report to view the information.
Financial Auditors:
Purchase the Salus Veletrgovina D.o.o. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Nensi D.o.o.
35%
Company Performance
Financial values in the chart are available after Salus Veletrgovina D.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.21%
Total operating revenue
12.19%
Operating profit (EBIT)
-5.4%
EBITDA
-4.71%
Net Profit (Loss) for the Period
-13.75%
Total assets
1.47%
Total equity
4.6%
Operating Profit Margin (ROS)
-0.3%
Net Profit Margin
-0.41%
Return on Equity (ROE)
-2.63%
Debt to Equity Ratio
-7.85%
Quick Ratio
0.04%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?